Britain is first to approve Merck’s Covid-19 pill molnupiravir

Britain on Thursday became the first country in the world to approve a potentially game-changing Covid-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.The Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, be used as soon as possible following a positive Covid-19 test and within five days of the onset of symptoms.This is the first oral antiviral treatment for Covid-19 to get…

Read the original article at South China Morning Post